Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 49-50 , March 2010

Editorial Comment

References 

  1. Haskins B, Harrison M. Huntington disease. Curr Treat Options Neurol. 2000;2:243–262
  2. Warby S, Graham R, Hayden M. Huntington disease. http://www.genetests.orgAccessed January 27, 2010
  3. Semaka A, Creighton S, Warby S, et al. Predictive testing for Huntington disease: Interpretation and significance of intermediate alleles. Clin Genet. 2006;70:283–294
  4. Went J. Ethical issues policy statement on Huntington's disease molecular genetics predictive test (International Huntington Association; World Federation of Neurology). J Med Genet. 1990;27:34–38
  5. Nance M. The Juvenile Huntington Disease Handbook: A Guide for Families and Caregivers. (ed 2). New York: Huntington Disease Society of America; 2007;
  6. Brouwer-DudokdeWit AC, Savenije A, Zoeteweij MW, et al. A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm. Fam Process. 2002;4:677–692
  7. Quaid K. Presymptomatic testing for Huntington disease: Recommendations for counseling. J Genet Couns. 1992;1:277–302
  8. Chapman E. Ethical dilemmas in testing for late onset conditions: Reactions to testing and perceived impact on other family members. J Genet Couns. 2002;11:351–367
  9. Quaid K, Sim SL, Swenson MM, et al. Living at risk: Concealing risk and preserving hope in Huntington disease. J Genet Couns. 2008;17:117–128

PII: S1071-9091(10)00014-8

doi: 10.1016/j.spen.2010.02.007

Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 49-50 , March 2010

Article Tools